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DNA damage responseMany herpesvirus-encoded protein kinases facilitate viral lytic replication. Importantly, the role of viral
kinases in herpesvirus latency is less clear. Mouse gammaherpesvirus-68 (MHV68)-encoded protein kinase
orf36 facilitates lytic replication in part through activation of the host DNA damage response (DDR). Here we
show that MHV68 latency was attenuated in the absence of orf36 expression. Unexpectedly, our study
uncovered enzymatic activity-independent role of orf36 in the establishment of MHV68 latency following
intraperitoneal route of infection. H2AX, an important DDR protein, facilitates MHV68 lytic replication and
may be directly phosphorylated by orf36 during lytic infection. In this study, H2AX deﬁciency, whether
systemic or limited to infected cells, attenuated the establishment of MHV68 latency in vivo. Thus, our work
reveals viral kinase-dependent regulation of gammaherpesvirus latency and illuminates a novel link
between H2AX, a component of a tumor suppressor DDR network, and in vivo latency of a cancer-associated
gammaherpesvirus.in, 8701 Watertown Plank Rd,
a).
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Cellular protein kinases are critical components of every signaling
pathway and represent an elegant tool that regulates many aspects of
cell biology. This important cellular tool is usurped by viruses, as all
avian and mammalian herpesviruses encode a protein kinase. Herpes-
virus protein kinases are separated into HvUs and HvUL families based
on amino acid sequence homology (reviewed in Gershburg and Pagano,
2008; Prichard, 2009). Alphaherpesviruses encode members of both
protein kinase families, whereas beta- and gammaherpesviruses
encode a single HvUL protein kinase.While these enzymes are divergent
at the amino acid level, herpesvirus kinases have highly conserved
biological roles in viral infection. Herpesvirus protein kinases are virion
components that localize to the nucleus and facilitate viral DNA
replication and egress (Gershburg et al., 2007; Moffat et al., 1998;
Krosky et al., 2003; Wolf et al., 2001; Chang et al., 2009; Gershburg and
Pagano, 2008). Protein kinases encoded by gammaherpesviruses target
multiple viral and host processes. Orf36 protein kinase encoded by
Kaposi's sarcoma-associated herpesvirus (KSHV) phosphorylates Kru-
pell-associated box domain-associated protein 1 to facilitate a switch
from latency to lytic replication in cell lines (Chang et al., 2009). BGLF4,
a kinase encoded by human Epstein–Barr virus (EBV), facilitates
expression of select viral genes, viral DNA synthesis, disassembly ofthe nuclear lamina, inhibition of cellular DNA synthesis, and cellular
chromosome condensation (reviewed in Gershburg and Pagano, 2008).
Orf36, a kinase encoded by mouse gammaherpesvirus 68 (MHV68), is
necessary for the initiation of the DNA damage response (DDR) in
lytically infected primary macrophages (Tarakanova et al., 2007). The
ability of orf36 to induce DDR is not unique, as expression of BGLF4 is
also sufﬁcient to induce DDR (Tarakanova et al., 2007), suggesting that
targeting of DDR by herpesvirus kinases may be a conserved biological
phenotype. Another conserved biological function is the interaction of
MHV68 orf36 and EBV BGLF4 with interferon regulatory factor 3 (IRF3)
and subsequent inhibition of its transcriptional activity (Hwang et al.,
2009).
While many herpesvirus kinases are known to facilitate viral
replication, there is a paucity of studies examining the role of these
enzymes during viral latency in vivo. Deletion of either orf47 or orf66
varicella-zoster virus (VZV) protein kinase does not have an effect on
the establishment of latency in dorsal root ganglia of infected rodents
(Sato et al., 2003), suggesting that either VZV kinases do not play a
role in viral latency or that the presence of the second herpesvirus
kinase is sufﬁcient to functionally compensate for the missing
counterpart. Interestingly, infection of micewith US3-deﬁcient herpes
simplex virus-2 (HSV-2) leads to an increased number of apoptotic
neurons, many of which stain positive for HSV antigens, suggesting
that US3 kinase is important for protection against cell death during
HSV latency (Asano et al., 2000).
MHV68 is a rodent gammaherpesvirus genetically and biologically
related to human EBV and KSHV and simian herpesvirus saimiri (HVS)
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latency in a variety of cell types, including macrophages, B cells, and
dendritic cells (Flano et al., 2000; Sunil- Chandra et al., 1992; Weck
et al., 1999a,b; Willer and Speck, 2003). MHV68-encoded protein
kinase orf36 has two physiologically relevant functions: induction of
DDR during lytic replication in primary macrophages and counterac-
tion of type I interferon response via inhibition of IRF3 (Hwang et al.,
2009; Tarakanova et al., 2007). Recently, both the expression and
kinase activity of MHV68 orf36 were shown to facilitate early splenic
latency following intranasal inoculation (Hwang et al., 2009),
suggesting that orf36-mediated induction of DDR and/or inhibition
of IRF-3 may contribute to the establishment of splenic latency in vivo.
The type I interferon response controls MHV68 reactivation from
latency at 28 days post infection (Barton et al., 2005); however, the
relationship between DDR and herpesvirus latency is less clear. While
attenuated DDR skews the choice of HSV life cycle towards latency in
cell culture systems (Lilley et al., 2005), the interplay between DDR
and herpesvirus latency in vivo is not understood.
The DDR is a conserved network of protein–protein interactions
and modiﬁcations that orchestrates detection and repair of lesions
in cellular DNA (reviewed in Pandita and Richardson, 2009). This
signaling network acts as an anti-cancer barrier and is activated
during an early stage of tumorigenesis in a majority of human cancers
(Bartkova et al., 2005; Bartek et al., 2007). Mutations of genes
encoding members of the DDR network, if compatible with normal
development, are associated with various degrees of genome
instability, immune deﬁciencies, and increased risk of tumorigenesis.
H2AX is a core histone 2A (H2A) variant that constitutes 2–25% of all
H2A incorporated into nucleosomes (Rogakou et al., 1998). H2AX has
a unique C-terminal amino acid sequence that is rapidly phosphor-
ylated early in DDR by ATM, ATR (ATM-related kinase), or DNA-PK to
function as a scaffold for the assembly of multi-protein complexes at
the DNA lesion. Two independently generated strains of H2AX
deﬁcient mice exhibit increased sensitivity to irradiation, increased
genomic instability, and defective DNA repair (Bassing et al., 2002,
2003; Celeste et al., 2002). H2AX deﬁcient mice display mild immune
defects, including a twofold reduction in the numbers of mature B and
T lymphocytes, but no apparent block in the development of these
cell types (Celeste et al., 2002). However, defective class switch
recombination leads to decreased levels of IgA and IgG in H2AX
deﬁcient mice, despite normal B cell proliferation (Celeste et al.,
2002).
DDR is actively engaged by many DNA viruses, including herpes-
viruses, in lytically infected cells (reviewed in Lilley et al., 2007; Lilley
et al., 2009). Speciﬁcally, MHV68 orf36 mediates phosphorylation of
serine 139 of H2AX during lytic infection (Tarakanova et al., 2007).
Furthermore, H2AX facilitates MHV68 replication in primary macro-
phages (Tarakanova et al., 2007). However, it is not clearwhether H2AX
expression affects MHV68 latency. In this study, we show that MHV68
kinase orf36 facilitates viral latency in vivo. Unexpectedly, our studies
have uncovered an enzymatic activity-independent function of orf36
during the establishment of viral latency. Furthermore, deﬁciency of
H2AX, either systemic or limited to infected cells, constrained the
establishment of MHV68 latency in a route of inoculation-speciﬁc
manner, suggesting that gammaherpesviruses may usurp components
of DDR not only during lytic replication, but also during latent infection
in vivo.
Results
Expression and enzymatic activity of MHV68 kinase orf36 are required
for the establishment of latency following intranasal inoculation
To deﬁne the role of orf36 in the establishment of MHV68 latency,
BL6 mice were intranasally inoculated with 104 PFU of wild type
MHV68, a viral mutant incapable of expressing orf36 (N36S), or a36KN virus that expresses an enzymatically inactive orf36 due to a
single amino acid substitution of lysine 107 (Hwang et al., 2009).
Frequencies of MHV68 DNA-positive cells and ex vivo reactivation
were measured in splenocytes and peritoneal exudate cells (PEC)
harvested at 16 days post infection as previously described (Weck
et al., 1996, 1999b). The frequency of MHV68 genome positive cells
was decreased 16- to 20-fold in splenocytes harvested from mice
infected with orf36 MHV68 mutant viruses as compared to wild type-
infected splenocytes (Fig. 1A; 1 in 143 cells positive for wild type
MHV68 vs. 1 in 2297 or 1 in 2917 cells positive for N36S and 36KN
mutant virus, respectively). The frequencies of ex vivo reactivation
were also decreased in splenocytes harvested from N36S or 36KN-
infected mice as compared to wild type-infected controls (Fig. 1B).
The decrease in the frequency of ex vivo reactivation appeared to be
similar in magnitude to the decrease in the frequency of MHV68
genome positive cells (Fig. 1A). Therefore, in spite of fewer MHV68
positive splenocytes in mice infected with orf36 mutant viruses, the
same proportion of infected splenocytes reactivated ex vivo, suggest-
ing that the viral kinase is not required for the efﬁciency of
reactivation under these experimental conditions. The frequencies
of infected cells and ex vivo reactivation were decreased in PEC
harvested from mice latently infected with either orf36 mutant
(Figs. 1C and D). Thus, following intranasal inoculation, both orf36
expression and enzymatic activity facilitated establishment of MHV68
latency in the spleen and peritoneum.
Orf36 expression, but not kinase activity, is required for early MHV68
latency establishment following intraperitoneal inoculation
Because MHV68 acute replication is attenuated in vivo in the
absence of orf36 (Hwang et al., 2009; Tarakanova et al., 2007), this
could delay dissemination of orf36 MHV68 mutants to spleen and
peritoneum with the subsequent delay in the establishment of
latency. Furthermore, a route of inoculation-dependent splenic
latency phenotype had been described for the MHV68 virus mutant
lacking expression of M2 protein (Herskowitz et al., 2005). Therefore,
we wanted to determine whether direct inoculation of orf36 MHV68
mutants into peritoneum would overcome the defect in the
establishment of latency that was seen following intranasal inocula-
tion (Fig. 1). BL6 mice were intraperitoneally infected with 104 PFU of
wild type MHV68 or either of the orf36 mutants described above and
splenocytes and PEC harvested at 16 days post infection. The
frequency of latently infected splenocytes was decreased approxi-
mately 6-fold inmice infectedwith N36Smutant virus as compared to
wild type infection (1 in 239 splenocytes for wild type virus vs. 1 in
1505 splenocytes for N36S mutant, pb0.05; Fig. 2A). Interestingly, the
frequency of splenocytes infected with the 36KN mutant was similar
to that measured in the wild type-infected group (1 in 239 for wild
type virus vs. 1 in 464 for 36KN mutant, pN0.05, Fig. 2A). The
frequency of ex vivo reactivation from splenocytes was signiﬁcantly
decreased for both orf36 mutants (Fig. 2B). These data suggested that
orf36 expression was required to establish an adequate pool of
latently infected splenocytes and to support efﬁcient MHV68
reactivation ex vivo. However, orf36 enzymatic activity was dispens-
able for the establishment of a reservoir of latently infected
splenocytes following intraperitoneal inoculation.
In the peritoneum, the frequency of N36S-infected PEC was
decreased approximately 4-fold compared to wild type infection (1
in 154 vs. 1 in 589 cells; Fig. 2C). On the contrary, the frequency of
36KN-infected PEC was indistinguishable from that observed in wild
type MHV68-infected mice (1 in 154 vs. 1 in 151 cells; Fig. 2C). The
frequency of ex vivo reactivation was decreased approximately 12-
fold in PEC infected with N36S mutant as compared to wild type virus
(1 in 234 vs. 1 in 2895 cells; Fig. 2D), suggesting that orf36 expression
was required for both the number of latently infected PEC and
efﬁciency of ex vivo reactivation. The frequency of ex vivo reactivation
Fig. 1. Expression and enzymatic activity of MHV68 kinase orf36 are required for the establishment of latency following intranasal inoculation. BL6 mice were intranasally inoculated
with 104 PFU of wild type MHV68, N36S viral mutant incapable of expressing orf36 kinase, or 36KN viral mutant expressing an enzymatically inactive orf36. Splenocytes and
peritoneal exudate cells (PEC) were harvested at 16 days post infection and pooled from 3 to 5 mice in each experimental group. Frequencies of infected cells (A, C) and ex vivo
reactivation (B, D) were determined in indicated experimental groups using limiting dilution assays. Data were pooled from 3 to 4 independent experiments.
Fig. 2. Orf36 expression but not kinase activity is required for early MHV68 latency establishment following intraperitoneal inoculation. BL6 mice were intraperitoneally infected
with 104 PFU of wild type MHV68, N36S, or 36KN virus mutants. Splenocytes and PEC were harvested and pooled from 3 to 5 mice in each experimental group at 16 days post-
infection and frequencies of infected cells (A, C) and ex vivo reactivation (B, D) determined using limiting dilution assays. Data were pooled from 3 independent experiments.
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mice, and this differencewas not statistically signiﬁcant (1 in 234 cells
for wild type virus vs. 1 in 492 cells for 36KN, pN0.05; Fig. 2D). Thus,
following intraperitoneal inoculation, orf36 expression, but not its
enzymatic activity, was required for efﬁcient latency establishment in
the peritoneum. With the exception of the reactivation phenotype in
spleen following intraperitoneal inoculation, our studies revealed a
route of infection-speciﬁc role of orf36 enzymatic activity in MHV68
latency establishment.
Orf36 does not affect the distribution of latently infected cells between
CD93-positive and -negative splenic B cell populations
Early MHV68 latency is associated with changes in splenic B cell
populations, including increases in germinal center B cells, CD138+
plasma cells, and polyclonal B cell activation (Collins et al., 2009;
Sangster et al., 2000; Stevenson and Doherty, 1999; Liang et al., 2009;
Siegel et al., 2009). Some of these changes are driven by the MHV68-
encoded M2 protein (Siegel et al., 2008; Liang et al., 2009). Despite
these obvious changes to the B cell compartment, which B cell subsets
harbor latent virus remains somewhat controversial. Studies have
shown that during early latency the frequency of MHV68 positive
cells is similar in IgD+ and IgD− splenic B cells, suggesting that both
naïve and terminally differentiated B cells harbor latent virus (Willer
and Speck, 2003). However, other studies suggest that during early
latency, MHV68 preferentially resides within B cells positive for the
germinal center markers, such as PNA and GL-7 (Collins et al., 2009;
Flano et al., 2000, 2003, 2002; Willer and Speck, 2003). In studies of
long-term latency, latently infected cells are mostly found in the IgD−
B cell compartment (Willer and Speck, 2003). Some of the
controversial results may have stemmed, in part, from the manipula-
tion of CD21 and CD23 on the surface of infected B cells (Collins et al.,
2009), making it difﬁcult to interpret some of the data.
Because the frequency of MHV68 positive splenocytes was
decreased in mice latently infected with orf36 MHV68 mutants, we
wanted to determine whether orf36 had a role in the distribution ofFig. 3. Orf36 does not affect the distribution of latently infected cells between CD93-positive
PFU of wild typeMHV68, N36S, or 36KN viral mutant. Splenocytes were harvested and pooled
antibodies and analyzed by ﬂow cytometry (A-representative result). (B, C) Splenocytes we
using limiting dilution nested PCR assay. Data were pooled from 3 to 4 independent experilatently infected cells among splenic B cell populations. We used CD93
to differentiate newly emerged transitional B cells frommore mature B
cells, including follicular B cells andmarginal zone B cells (Allman et al.,
2001), and investigate whether orf36 plays a role in establishing
latency in these splenic B cell subsets. BL6 mice were intranasally
inoculated with wild type MHV68 or orf36 virus mutants, splenocytes
harvested at 16 days post infection and pooled within each group with
subsequent staining with CD93 and B220 (Fig. 3A). Infection did not
result in gross changes to the normal distribution of B220+CD93+ cells,
although those receiving the N36S or 36KNMHV68 mutants presented
with marginal increases in this population based on whole splenocytes
(Fig. 3A).
Pooled splenocytes within each experimental group were sorted
into CD93+B220+ (transitional B cells), CD93−B220+ (follicular and
marginal zone B cells), and B220− (non-B-cell) populations and the
frequency of MHV68 positive cells determined by limiting dilution
nested PCR. The frequencies of MHV68 positive cells were similar in
CD93-positive (1 in 477 cells) and CD93-negative (1 in 337 cells) B
cell populations isolated from wild type MHV68-infected spleens
(Fig. 3B). As expected, a signiﬁcantly lower frequency of MHV68
positive cells was found in B220-negative splenocyte population
(Fig. 3B). Although the frequency of MHV68 positive cells was lower
in sorted splenocytes harvested from N36S-infected mice, MHV68
genome positive cells had a similar distribution between CD93-
positive and -negative B cell subsets (1 in 2822 cells and 1 in 1485
cells, respectively; Fig. 3C). Distribution of 36KN-infected splenocytes
was similar to that observed for the N36S-infected group (data not
shown). Thus, neither expression nor enzymatic activity of orf36 had
an effect on the distribution of latently infected cells between CD93-
positive and -negative B cell subsets.
Orf36 expression and enzymatic activity facilitate MHV68 reactivation
during long-term latency
Between 16 and 42 days post infection, MHV68 transitions from
early latency to a more stable long-term condition with a decreaseand -negative splenic B cell populations. BL6 mice were intranasally inoculated with 104
from 3 to 5mice/group at 16 days post infection, stainedwith anti-B220 and anti-CD93
re sorted into indicated populations and frequency of MHV68 infected cells determined
ments for each sorted population.
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loss of efﬁcient reactivation ex vivo (Moser et al., 2005; Tibbetts et al.,
2003). To determine whether orf36 expression had an effect on long-
term MHV68 latency in wild type mice, BL6 mice were intraper-
itoneally infected as described above and splenocytes and PEC
harvested at 42 days post infection. The frequencies of MHV68 DNA-
positive PEC and splenocytes were indistinguishable in mice infected
with wild type MHV68 or either of the two orf36 viral mutants
(Figs. 4A and C). However, the frequencies of ex vivo reactivation were
signiﬁcantly lower in PEC harvested from mice infected with either
N36S or 36KN virus mutant (1 in 11,000 for wild type virus vs. N1 in
40,000 for either orf36 mutant; Fig. 4B). Ex vivo reactivation from
long-term infected splenocytes was too low to determine the role of
orf36 in this process. Long-term latency was also examined in
intranasally infected mice. Similar to intraperitoneal inoculation, the
frequencies of infected splenocytes and PEC were similar in all groups
at 42 days post-intranasal infection (data not shown). Thus, while the
expression and enzymatic activity of orf36 were dispensable for the
establishment of pool of MHV68 positive cells at 42 days post
infection, orf36 contributed to efﬁcient viral reactivation from PEC
of long-term infected mice.
H2AX facilitates efﬁcient establishment of MHV68 early latency
Having deﬁned the contribution of orf36 to theMHV68 latency, we
wanted to determine whether H2AX, an important member of the
DDR network and a potential substrate of orf36 in lytic infection
(Tarakanova et al., 2007), played a role in the establishment of MHV68
latency. H2AX deﬁcient, heterozygous, or wild type littermates were
intranasally infected with 104 PFU of wild type MHV68, and theFig. 4. Orf36 expression and enzymatic activity facilitate MHV68 reactivation in long-term
MHV68, N36S, or 36KN viral mutant. Splenocytes and PEC were harvested and pooled from
infected cells (A, C) and ex vivo reactivation (B) determined using limiting dilution assays.frequencies of ex vivo reactivation and viral genome positive cells
were measured in splenocytes and PEC harvested at 17 days post
infection. The frequency of MHV68 genome positive cells was
decreased approximately 5-fold in splenocytes harvested from
H2AX deﬁcient mice as compared to wild type and heterozygous
littermates (1 in 87 for wild type mice vs. 1 in 447 for H2AX deﬁcient
mice, p=0.0406, Fig. 5A), indicating that H2AX contributed to the
efﬁcient establishment of the pool of latently infected splenocytes.
The frequency of ex vivo reactivation was slightly decreased in
splenocytes harvested from H2AX deﬁcient mice as compared to
wild type and heterozygous counterparts (Fig. 5B); however, this
decrease was not statistically signiﬁcant. Frequencies of MHV68
genome positive cells and ex vivo reactivation were similar in PEC
harvested from all three experimental groups (Figs. 5C and D).
Overall, systemic H2AX deﬁciency led to a signiﬁcant decrease in the
frequency of latently infected splenocytes, but only a mild attenuation
of other MHV68 early latency parameters.
To determine the effect of combined orf36 and H2AX deﬁciency on
the establishment of MHV68 latency, H2AX deﬁcient mice or wild
type littermates were intranasally infected with 104 PFU of wild type
MHV68 or the N36S mutant and the frequency of viral genome
positive cells was measured in splenocytes harvested at 16 days post
infection. As expected, the frequencies of MHV68 genome positive
cells were decreased in H2AX deﬁcient mice infected with wild type
MHV68 and in wild type mice infected with the N36S mutant
(Fig. 5E). Importantly, systemic H2AX deﬁciency of the host further
decreased the frequency of N36S infected splenocytes compared to
that observed in wild type mice infected with the N36S mutant
(Fig. 5E, pb0.05). Thus, orf36 and H2AX had additive effects during
the establishment of MHV68 latency.infected mice. BL6 mice were intraperitoneally inoculated with 104 PFU of wild type
3 to 5 mice in each experimental group at 42 days post infection and frequencies of
Fig. 5.H2AX facilitates efﬁcient establishment of MHV68 splenic latency. H2AXwild type, heterozygous (het), or deﬁcient (KO)mice were intranasally infected with 104 PFU of wild-
type MHV68 (or N36S viral mutant in E). Splenocytes and PEC were harvested at 16 days post infection and pooled from 3 to 5 mice in each experimental group. Frequencies of
infected cells (A, C, E) and ex vivo reactivation (B, D) were determined in indicated experimental groups using limiting dilution assays. Data were pooled from 3 to 4 independent
experiments.
55V.L. Tarakanova et al. / Virology 405 (2010) 50–61Efﬁcient establishment of early MHV68 latency is dependent on the
presence of H2AX within the latently infected cell
An important caveat of MHV68 latency studies in H2AX deﬁcient
mice is the presence of the immune deﬁciencies, such as decrease in B
and T cell numbers and defective class switching, identiﬁed in these
mice in the absence of pathogen challenge (Celeste et al., 2002). To the
best of our knowledge, there are no reports examining immune
responses of H2AX deﬁcient mice challenged with a live pathogen.
Therefore, it is possible that known immune defects become
exacerbated or additional immune deﬁciencies are exposed upon
challenge of H2AX deﬁcient mice with MHV68. Because many
effectors of immune system, including B and T cells, control MHV68
latency (reviewed in Stevenson and Efstathiou, 2005), the parameters
of early latency in H2AX deﬁcient mice are likely to combine effects of
H2AX deﬁciency within the latently infected cells and systemic effects
on the immune system. To circumvent this caveat, we analyzedMHV68 latency establishment in a mouse model where H2AX
deﬁciency is limited to infected cells.
H2AX deﬁcient mice were generated from a mouse embryonic
stem (ES) cell line containing H2AX gene ﬂanked by loxP sites
(Bassing et al., 2002). This ES cell line gave rise to the mouse strain
with systemic H2AX deletion (via expression of Cre recombinase in ES
cells) as well as the H2AX ﬂox/ﬂox mouse strain that allows
conditional deletion of H2AX in vivo (Bassing et al., 2002, 2003). To
determine whether H2AX deﬁciency limited to MHV68-infected cells
had an effect on viral latency, H2AX ﬂox/ﬂox mice were intranasally
infected with 104 PFU of wild type MHV68 or the MHV68-Cre virus
containing a CMV promoter-driven Cre recombinase transgene
inserted into the 27b-29 locus of the MHV68 (Moser et al., 2005).
Importantly, insertion of the Cre transgene has no detectable effects
on the ability of MHV68-Cre virus to replicate or establish latency in
wild type mice, while allowing efﬁcient deletion of loxP-ﬂanked
sequences in mouse models with conditional genetic deﬁciencies
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and ex vivo reactivation were measured in splenocytes and PEC
collected at 15–16 days post infection.
The frequency of MHV68 genome positive splenocytes was
signiﬁcantly decreased (approximately 6-fold) in H2AX ﬂox/ﬂox
mice infected with MHV68-Cre virus as compared to wild type virus-
infected controls (1 in 95 cells for wild type virus vs. 1 in 600 cells for
MHV68-Cre; Fig. 6A). Concurrent with decrease in the frequency of
latently infected cells, the frequency of ex vivo reactivation was also
decreased in MHV68-Cre-infected splenocytes (Fig. 6B). The frequen-
cies of MHV68 genome positive cells as well as ex vivo reactivation
were decreased in PEC harvested from MHV68-Cre-infected mice
(Figs. 6C and D). Thus, speciﬁc deletion of H2AX within the infected
cell led to a signiﬁcant attenuation of early MHV68 latency in the
spleen and peritoneum. Notably, at 28 days post infection, the
frequencies of MHV68 positive cells and ex vivo reactivation were
indistinguishable between wild type and MHV68-Cre-infected H2AX
ﬂox/ﬂox mice (data not shown).
H2AX deﬁciency has no effect on acute MHV68 replication in vivo
MHV68 orf36 facilitates acute MHV68 replication in vivo (Hwang
et al., 2009; Tarakanova et al., 2007) To determine whether H2AX
deﬁciency affects MHV68 acute replication in mouse lungs, H2AX
wild type or deﬁcient mice were intranasally inoculated with 104
PFU of wild type MHV68 and lytic virus measured in lungs at 4 days
post infection, during the peak of viral replication. MHV68 titers were
similar in lungs of H2AX deﬁcient mice and wild type littermates
(Fig. 7A). Similar peak lung titers were also observed upon infection of
H2AX ﬂox/ﬂox mice with wild type MHV68 or MHV68-Cre (Fig. 7B).
Thus, neither systemic nor infected cell-speciﬁc H2AX deﬁciency had
an effect on the acute MHV68 replication in the lung.Fig. 6. Efﬁcient establishment of early MHV68 latency is dependent on the presence of H2AXw
PFU of wild type MHV68 or MHV68-Cre. Splenocytes and PEC were harvested at 16 days p
infected cells (A, C) and ex vivo reactivation (B, D) were determined in indicated experi
experiments.H2AX exerts a route of infection-dependent effect on early MHV68
latency
The enzymatic activity of MHV68 orf36 had a route of infection-
dependent contribution during the establishment of MHV68 latency
(Fig. 2). Because H2AX may be a substrate of orf36 kinase, we
wanted to determine whether H2AX may also modulate MHV68
latency in a route of infection-dependent manner. H2AX ﬂox/ﬂox
mice were intraperitoneally infected with 104 PFU of wild type
MHV68 or MHV68-Cre. Frequencies of viral genome positive cells
and ex vivo reactivation were measured in splenocytes and PEC
harvested at 16 days post infection. The frequencies of MHV68
genome positive cells were similar in splenocytes harvested from
both experimental groups (1 in 93 cells for wild type virus vs. 1 in
202 cells for MHV68-Cre; Fig. 8A). However, a small but statistically
signiﬁcant decrease was observed in the frequency of ex vivo
reactivation from MHV68-Cre-infected splenocytes as compared to
wild type infected group (Fig. 8B), indicating that H2AX expression
within latently infected splenocytes facilitated ex vivo reactivation.
Similar frequencies of viral genome positive cells were also
observed in PEC (1 in 68 for wild type virus vs. 1 in 93 for
MHV68-Cre; Fig. 8C). Frequencies of ex vivo reactivation from
latently infected PEC were indistinguishable between two experi-
mental groups (Fig. 8D). Similar data were obtained in H2AX wild
type and deﬁcient mice intraperitoneally inoculated with wild type
MHV68 (data not shown). Thus, we found that, analogous to the
phenotype of the 36KN virus mutant, H2AX deﬁciency had a route
of inoculation-dependent effect on the establishment of MHV68
latency.
To assess whether H2AX contributes to long-term MHV68
latency, H2AX ﬂox/ﬂox mice were intraperitoneally infected with
104 PFU of wild type MHV68 or MHV68-Cre and frequency of viralithin the latently infected cell. H2AX ﬂox/ﬂoxmice were intranasally infectedwith 104
ost infection and pooled from 3 to 5 mice in each experimental group. Frequencies of
mental groups using limiting dilution assays. Data were pooled from 3 independent
Fig. 7.H2AX deﬁciency has no effect on acute MHV68 replication in lungs. H2AXwild type or deﬁcient mice (A) or H2AX ﬂox/ﬂoxmice (B) were intranasally infected with 104 PFU of
indicated viruses. Lungs were harvested at 4 days post infection, homogenized, and viral titers measured. Each symbol represents an individual mouse.
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post infection. The frequency of MHV68 DNA-positive PEC was
decreased in mice infected with the MHV68-Cre virus as compared
to wild type virus infection (1 in 1743 vs. 1 in 5451 cells, p=0.03;Fig. 8. H2AX has a route of infection-dependent effect on MHV68 latency. H2AX ﬂox/ﬂox m
Splenocytes and PECwere harvested at 16 days (A–D) or 42 days (E, F) post infection and poo
and ex vivo reactivation (B, D) were determined in indicated experimental groups using limFig. 8E). However, the frequencies of MHV68 DNA-positive spleno-
cytes were similar in mice infected with either wild type (1 in 1505
cells) or MHV68-Cre virus (1 in 2761 cells; Fig. 8F). Thus, deletion of
H2AX within infected cells had long-term effects on MHV68 latency.ice were intraperitoneally infected with 104 PFU of wild type MHV68 or MHV68-Cre.
led from 3 to 5mice in each experimental group. Frequencies of infected cells (A, C, E, F)
iting dilution assays. Data were pooled from 3 independent experiments.
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This study presents a comprehensive analysis of the role of a
conserved gammaherpesvirus kinase in the establishment and
maintenance of viral latency in vivo. Furthermore, this is the ﬁrst
study to show that H2AX, a critical component of the host DDR
network, modulates gammaherpesvirus latency in vivo. Our experi-
ments reveal an interesting correlation between the phenotypes of
MHV68 latency in an H2AX deﬁcient host and latency phenotypes
seen in mice infected with MHV68 mutant expressing an enzymat-
ically inactive viral kinase (36KN; Table 1). Experiments presented
here also suggest the possibility that the physiologically relevant
functions of gammaherpesvirus kinases extend beyond the ability of
the viral protein to phosphorylate substrates.
The role of orf36 in MHV68 latency
Our studies indicate that orf36 expression and enzymatic activity
modulate both the establishment and long-term maintenance of
MHV68 latency in vivo. The requirement for orf36 during the
establishment of MHV68 latency (Figs. 1 and 2) and MHV68
reactivation from long-term infected PEC (Fig. 4B) suggests that
orf36 most likely functions during viral reactivation from latency.
Indeed, orf36 is expressed with early–late kinetics in MHV68-infected
ﬁbroblasts (Martinez-Guzman et al., 2003) and facilitatesMHV68 lytic
replication in vitro in a cell type-speciﬁc manner (Tarakanova et al.,
2007). Furthermore, MHV68 reactivation from latency is likely to
facilitate both the establishment of splenic latency and long-term
infection (Li et al., 2008; Liang et al., 2009; Siegel et al., 2009). The
modulation of latent MHV68 infection by a lytic viral protein is not
unprecedented. In fact, MHV68-encoded v-cyclin is one example of a
lytic viral protein that is required for efﬁcient establishment and
maintenance of MHV68 latency (Van Dyk et al., 2000, 2003; Upton
and Speck, 2006). However, we also cannot rule out that orf36
functions in latently infected cells independent of viral reactivation.
While orf36 expression was not detected in a tumor cell line latently
infected with MHV68 (Martinez-Guzman et al., 2003), the expression
of orf36 during viral latency in vivo has not been formally excluded.
Importantly, expression of KSHV orf36 kinase is induced by hypoxia in
latently infected cell lines (Haque et al., 2006), suggesting that certain
stimuli may induce viral kinase expression in latently infected cells in
the absence of bona ﬁde reactivation.
In our study, we entertained a possibility that the tropism of
MHV68 for splenic B cell subpopulations would be altered in the
absence of orf36 expression, thus leading to attenuation of latency in
the spleen. Interestingly, we found that the frequencies of infected
cells were similar between the transitional (CD93+B220+) and
follicular and marginal zone B cell populations (CD93−B220+)
irrespective of the orf36 status (Figs. 3B and C). While previousTable 1
Summary of in vivo phenotypes of orf36 MHV68 mutants and H2AX deﬁcient host during e
Deﬁciency of Route of inoculation Fre
Orf36 expression Intraperitoneal Sp
PE
Orf36 enzymatic activity Intraperitoneal Sp
H2AX within infected cells (H2AX ﬂox/ﬂox) Intraperitoneal Sp
Orf36 expression Intranasal Sp
PE
Orf36 enzymatic activity Intranasal Sp
PE
H2AX within infected cells (H2AX ﬂox/ﬂox) Intranasal Sp
PE
a Compared to wild type virus.
b Low-frequency precluded precise quantitation.studies have shown that the majority of MHV68 infected splenic B
cells during early latency are positive for germinal center markers
(Collins et al., 2009; Flano et al., 2000, 2002, 2003; Willer and Speck,
2003), our data would suggest that transitional B cells also support
viral latency. This suggests that identiﬁcation of B cell subsets that
support latent infection may be more complicated than previously
appreciated. This observation warrants future studies of the interac-
tion of MHV68 with “immature” B cell populations and locale of
terminally differentiated B cells during the establishment of latency.
The role of orf36 enzymatic activity in MHV68 latency
The interpretation of the 36KN latency phenotype is complicated
by the poor understanding of cell types infected with MHV68 during
the ﬁrst 10–12 days post infection. Furthermore, trafﬁcking of
MHV68-infected cells during the ﬁrst 14 days of infection is not
clear. Recent studies utilizing luciferase expressing MHV68 mutants
showed that the kinetics of MHV68 distribution to different organs
vary based on the route of inoculation (Hwang et al., 2008; Milho
et al., 2009); however, the mechanism behind this route of
inoculation-dependent viral distribution is not known. It is not clear
whether route of inoculation plays a role in MHV68 pathogenesis. The
latency phenotype of the orf36.KN mutant is not unprecedented, as
the M2MHV68mutant also exhibits a route of inoculation-dependent
phenotype in the establishment of MHV68 latency (Herskowitz et al.,
2005). Interestingly, the splenic latency phenotype exhibited by the
M2 mutant following intraperitoneal inoculation can be rescued by
increasing the inoculum dose (Herskowitz et al., 2005; Jacoby et al.,
2002). This would suggest that a lower inoculum dose may reveal a
role for orf36 enzymatic activity in early MHV68 latency following an
intraperitoneal inoculation.
While the orf36 substrates have not been extensively character-
ized, H2AX and IRF3 are the two physiologically relevant substrates of
this kinase that play a role during MHV68 lytic replication and the
establishment of latency (Hwang et al., 2009; Tarakanova et al., 2007;
and this study). Importantly, combined orf36 and H2AX deﬁciency
had an additive effect in the attenuation of MHV68 latency (Fig. 5E),
suggesting that orf36 regulates multiple cellular processes (including
DNA damage response and type I interferon signaling) to facilitate
viral latency. Importantly, the kinase activity of orf36 was not
required to inhibit interferon beta reporter activity (Hwang et al.,
2009) or establish latency following intraperitoneal inoculation
(Fig. 2), suggesting that MHV68 orf36 is a multifunctional viral
protein, with only some of its functions dependent on the enzymatic
activity. This is signiﬁcant, as the pharmacological approaches that
target enzymatic activity of herpesvirus kinases (such as maribavir
and its derivatives)may only be partially effective, as these agents will
likely fail to inhibit enzymatic activity-independent viral kinase
functions. Interestingly, the latency phenotypes of the 36KN MHV68arly MHV68 latency.
quency of infected cellsa Frequency of ex vivo reactivationa
leen: decreased 6-fold Spleen: decreasedb
C: decreased 4-fold PEC: decreased 12-fold
leen and PEC: similar to wild type virus Spleen: decreasedb
PEC: similar to wild type virus
leen and PEC: similar to wild type virus Spleen: decreasedb
PEC: similar to wild type virus
leen: decreased 16- to 20-fold Spleen: decreasedb
C: decreasedb PEC: decreasedb
leen: decreased 16- to 20-fold Spleen: decreasedb
C: decreasedb PEC: decreasedb
leen: decreased 6-fold Spleen: decreasedb
C: decreasedb PEC: decreasedb
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absence of H2AX, suggesting that phosphorylation of H2AX by orf36
may be one of the mechanisms that regulate MHV68 latency and
reactivation in vivo.
The role of H2AX in MHV68 latency
In this study, we demonstrate that H2AX facilitates establishment
of MHV68 latency. We utilized mouse strains containing systemic or
conditional deletion of H2AX. The advantage of using the H2AX ﬂox/
ﬂox system is that speciﬁc deletion of H2AX within the infected
cells occurs in the context of a normal immune system. A greater
attenuation of early MHV68 latency observed in H2AX ﬂox/ﬂox mice
as compared to mice with global H2AX deﬁciency (Figs. 5 and 6)
suggests that the compromised immune system in H2AX deﬁcient
mice may indeed modulate the parameters of MHV68 latency.
Alternatively, H2AX may have previously unappreciated effects on B
cell development that could further affect MHV68 latency in mice
with systemic deletion of H2AX. The caveat of the ﬂox/ﬂox system is
that the deletion of H2AX requires viral entry and gene expression.
Furthermore, the efﬁciency of Cre-mediated gene excision in the
context of the MHV68-Cre virus has not been reported. Therefore, it is
possible that the effects of H2AX deﬁciency within latently infected
cells may be more profound than revealed by our studies due to
efﬁciency and/or timing of Cre-mediated H2AX deletion.
An important question that will be addressed in future studies is
the mechanism by which H2AX functions during MHV68 latency.
H2AX, one of the many H2A isoforms, appears to be redundant for
cellular chromatin assembly. However, unlike other H2A isoforms,
H2AX is a critical member of the DDR network (Yin and Bassing,
2008). The unique serine 139 of H2AX is phosphorylated shortly after
detection of DNA breaks and serves as a scaffold for DNA repair
proteins (Yin and Bassing, 2008). Serine 139 of H2AX is phosphor-
ylated in an orf36-dependent manner in MHV68 infection and H2AX
is required for efﬁcient viral replication in primary macrophages in
vitro (Tarakanova et al., 2007). It is possible that DDR activation,
including H2AX phosphorylation, occurs during viral reactivation
from latency. The phosphorylation of serine 139 may be the feature of
H2AX required to exert its effects in latently infected cells. Expression
of phosphorylation defective H2AX mutant (S139A) increases
sensitivity to DNA damage (Rios-Doria et al., 2009). Furthermore,
the phenotype of wild type MHV68 latency in H2AX deﬁcient cells
mirrors the latency phenotype of MHV68 36KNmutant that expresses
an enzymatically inactive viral kinase (Table 1). It is tempting to
speculate that, similar to lytic infection, orf36 may mediate H2AX
phosphorylation during the establishment of MHV68 latency.
H2AX may function in cis, through its association with MHV68
genome, or in trans, by facilitating DDR signaling via cellular
chromatin. The association of herpesvirus DNA with histones has
profound effects on viral gene expression and control of replication
and latency (reviewed in Knipe and Cliffe, 2008). Unfortunately,
chromatization of latent MHV68 genome in vivo is poorly understood.
Induction of DDR is associated with signiﬁcant changes in histone
modiﬁcations, including acetylation, phosphorylation, and methyla-
tion of speciﬁc residues that subsequently modulate transcriptional
activity of the chromatin in the vicinity of the DNA lesion (Pandita and
Richardson, 2009; Huertas et al., 2009; van Attikum and Gasser,
2009). Therefore, recruitment of H2AX to the viral chromatin and
subsequent activation of DDR may contribute to regulation of MHV68
gene expression during reactivation from latency. The role of DDR in
herpesvirus reactivation from latency is poorly understood. This issue
has been historically examined in conjunction with radiation or
chemotherapy treatment of cancer patients. However, in the clinical
setting it is frequently impossible to discriminate intrinsic effects of
DDR induction within latently infected cells and the effects of cancer-
associated immunosuppression that is further exacerbated byradiation or chemotherapy. Irradiation upregulates late HSV gene
expression in vitro in cells lytically infected with the gamma 34.5 HSV
mutant, but not the wild type virus (Mezhir et al., 2005). Unfortu-
nately, the cell-intrinsic effects of DDR induction on herpesvirus
reactivation from primary cells are not understood.
In summary, we have shown that the conserved gammaherpes-
virus kinase and an important component of DDR network both
regulate gammaherpesvirus latency in vivo. These ﬁndings raise
important implications for gammaherpesvirus pathogenesis. DDR
network functions as a tumor suppressor, and manipulations of this
network during gammaherpesvirus latency may contribute to
gammaherpesvirus-associated tumorigenesis.
Materials and methods
Animals
C57BL/6 J (BL6) mice were obtained from Jackson Laboratories
(Bar Harbor, Maine) and bred at the Medical College of Wisconsin,
Milwaukee, WI. H2AX deﬁcient and H2AX ﬂox/ﬂox mice were a kind
gift of Dr. Fred Alt (HHMI, Harvard Medical School). All mice were
housed in a speciﬁc pathogen-free barrier facility in accordance with
federal and institutional guidelines. Mice were infected between 7
and 10 weeks of age, and spleens and peritoneal exudate cells (PEC)
were harvested from euthanized mice at indicated days post infection
and processed as previously described (Van Dyk et al., 2000). All
experimental manipulations of mice were approved by the Institu-
tional Animal Care and Use Committee of the Medical College of
Wisconsin.
Virus infections
The derivation of orf36 mutant MHV68 viruses and a
corresponding wild type control virus was previously described
(Hwang et al., 2009; Tarakanova et al., 2007). MHV68-Cre was a kind
gift of Dr. Samuel Speck (Emory University School of Medicine). All
viruses were passaged and tittered on NIH 3 T12 cells as previously
described (Weck et al., 1996). Viruses were diluted in Dulbecco's
modiﬁed Eagle's medium and 15 or 200 μl per mouse was used for
intranasal or intraperitoneal inoculation, respectively. For acute
replication assays, lungs were harvested at 4 days post infection,
mechanically disrupted with 1 mm zirconia beads (Biospec products,
Bartlesville, OK), brieﬂy centrifuged to remove tissue particles, and
supernatants subjected to plaque assay using NIH 3 T12 cells.
Limiting-dilution assays
The frequency of cells reactivating MHV68 ex vivo and the
frequency of cells harboring viral genome were determined as
previously described (Weck et al., 1996). Brieﬂy, to determine the
frequency of cells reactivating virus ex vivo, serial twofold dilutions of
splenocytes or PEC suspensions harvested from infected mice were
plated onto monolayers of mouse embryonic ﬁbroblasts (MEF) at 24
replicates per dilution. In order to control for any pre-formed
infectious virus, twofold serial dilutions of mechanically disrupted
splenocytes or PEC were plated as above. MHV68 was allowed to
reactivate from splenocytes or PEC, and virus was further ampliﬁed
within the same well via subsequent replication in MEF. Cytopa-
thic effect was scored at 21 days post-plating in all replicates and
dilutions. Because primary MEF were used to amplify the virus, the
sensitivity of limiting dilution reactivation assay was a single plaque
forming unit of MHV68. Because the endpoint of viral ampliﬁcation in
MEF was measured, the limiting dilution reactivation assay was not
susceptible to variability of titers released from primary cells upon
viral reactivation ex vivo.
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splenocyte or PEC suspensions were plated in serial threefold
dilutions in a background of uninfected NIH 3 T12 cells (12 replicates
per dilution), digested with proteinase K, and subjected to nested PCR
using primers against orf72 sequences. Data were subjected to
nonlinear regression analysis (GraphPad Prism software, San Diego,
CA), and Poisson distribution was used to determine the frequencies
of reactivating or MHV68 genome positive cells.
Flow cytometry and cell sorting
Spleens frommock-, wild type-, N36S-, and 36KN-infected C57BL/6
mice were homogenized, red blood cells were lysed using RBC lysis
buffer (Sigma-Aldrich, Saint Louis, MO), and Fc receptors were blocked
according tomanufacturer's recommendations (24G2, BDPharmingen).
Cells were then stained with antibodies against B220-AF647 (RA3-6B2)
and CD93-PE (AA4.1- eBiosciences). Cells were sorted on the BD
FACSAria into 3 separate populations B220−CD93−, B220+CD93+, and
B220+CD93−with an average sort purity of greater than 96%, 91%, and
94%, respectively.
Statistical analyses
Data from limiting dilution assays were subjected to nonlinear
regression analysis (GraphPad Prism software, San Diego, CA). Based
on Poisson distribution, the intersection of linear regression curve
with 63.2% was used to determine the frequency of reactivating or
MHV68 genome positive cells. ANOVA or paired Student t-test were
used to determine statistical signiﬁcance in multi- or two-group
experiments, respectively (GraphPad Prism software, San Diego, CA).
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